Edited by Luke O'NeillC-reactive protein (CRP) is present at sites of inflammation including amyloid plaques, atherosclerotic lesions, and arthritic joints. CRP, in its native pentameric structural conformation, binds to cells and molecules that have exposed phosphocholine (PCh) groups. CRP, in its non-native pentameric structural conformation, binds to a variety of deposited, denatured, and aggregated proteins, in addition to binding to PCh-containing substances. In this study, we investigated the effects of H 2 O 2 , a prototypical reactive oxygen species that is also present at sites of inflammation, on the ligand recognition function of CRP. is a biological modifier of the structure and ligand recognition function of CRP. Overall, the data suggest that the ligand recognition function of CRP is dependent on the presence of an inflammatory microenvironment. We hypothesize that one of the functions of CRP at sites of inflammation is to sense the inflammatory microenvironment, change its own structure in response but remain pentameric, and then bind to pathogenic proteins deposited at those sites.
C-reactive protein (CRP)3 is a pentameric molecule made up of five non-covalently associated, identical subunits arranged symmetrically around a central pore (1, 2). The ligand recognition function of native pentameric CRP is to bind, in a Ca 2ϩ -dependent manner, to phosphocholine (PCh)-containing substances, such as pneumococcal cell wall C-polysaccharide (PnC), necrotic cells, platelet-activating factor, PCh-containing molecules on the surface of parasites, enzymatically modified LDL, and oxidized LDL (ox-LDL) if the oxidation was sufficient to expose the PCh groups present in LDL (3-10). Under certain conditions, such as in an acidic pH buffer, CRP adapts a different pentameric configuration that exposes a hidden ligandbinding site for non-PCh ligands and that enables CRP to bind to immobilized, denatured, and aggregated proteins, irrespective of the identity of the native protein (11)(12)(13) , respectively, also converts CRP into molecules that bind to a variety of immobilized, denatured, and aggregated proteins (11,14).CRP is a plasma protein that is present at sites of inflammation such as necrotic areas in local inflammatory lesions, synovium of patients with rheumatoid arthritis, inflammatory lesions of experimental allergic encephalomyelitis, inflammatory and arterial atherosclerotic lesions, and neurofibrillary tangles of Alzheimer's disease (15)(16)(17)(18)(19)(20)(21)(22). When CRP is present at sites of inflammation, it is exposed to an inflammatory microenvironment. The microenvironment at sites of inflammation including arterial lesions in atherosclerosis, inflammation in the eye and the sites of bacterial infection, is characterized by acidic pH, hypoxia, and increased O 2 and energy demand, which result in the production of reactive oxygen species (ROS), including H 2 O 2 , and subsequent dysregulation of the extracellular redox environment, which is known to cause modifications in the proteins prese...